Mauve factor re-identified as 2,4-dimethyl-3-ethylpyrrole and its sedative effect on the CNS.
D000818:Animals; D002490:Central Nervous System / Q000187:drug effects; D002606:Charcoal; D002725:Chloroform; D002746:Chlorpromazine / Q000627:therapeutic use; D002854:Chromatography, Paper; D002855:Chromatography, Thin Layer; D006801:Humans; D006993:Hypnotics and Sedatives / Q000494:pharmacology / Q000652:urine*; D011618:Psychotic Disorders / Q000652:urine; D011758:Pyrroles / Q000494:pharmacology / Q000652:urine*; D011817:Rabbits; D013053:Spectrophotometry; D013268:Stimulation, Chemical; D014268:Trifluoperazine / Q000627:therapeutic use
D006993:Hypnotics and Sedatives; D011758:Pyrroles; D002606:Charcoal; D014268:Trifluoperazine; D002725:Chloroform; D002746:Chlorpromazine